Stonepine Capital Management, LLC Quant / Systematic

Name: Stonepine Capital Management, LLC Q4 2015 13F Filing | 13F Explorer
Creator: Stonepine Capital Management, LLC
Published: 2016-02-11

Location: Bend, OR

CIK: 0001440771 · Show all filings

Period: Q4 2015 (Next →)

Filing Date: Feb 11, 2016

Total Value: $85.36M (100.0% shares, 0.0% debt)

Holdings (13)

VNDA VANDA PHARMACEUTICALS INC 20.9%

Value $17.86M Shares 1,918,929 Share Price $9.31 * Est. Cost/Share $9.98 Unrealized @ Report Date 0.0%

— CTI BIOPHARMA CORP 15.4%

Value $13.16M Shares 10,698,618 Share Price $1.23 Est. Cost/Share $1.23 Unrealized @ Report Date —

— SCICLONE PHARMACEUTICALS INC 12.7%

Value $10.81M Shares 1,175,574 Share Price $9.20 Est. Cost/Share $9.20 Unrealized @ Report Date —

— TOBIRA THERAPEUTICS INC 9.8%

Value $8.375M Shares 833,377 Share Price $10.05 Est. Cost/Share $10.05 Unrealized @ Report Date —

— SAGENT PHARMACEUTICALS INC 8.6%

Value $7.364M Shares 462,824 Share Price $15.91 Est. Cost/Share $15.91 Unrealized @ Report Date —

— PERNIX THERAPEUTICS HOLDINGS 8.6%

Value $7.33M Shares 2,484,649 Share Price $2.95 Est. Cost/Share $2.95 Unrealized @ Report Date —

— PAIN THERAPEUTICS INC 7.3%

Value $6.256M Shares 3,575,000 Share Price $1.75 Est. Cost/Share $1.75 Unrealized @ Report Date —

— FOUNDATION MEDICINE INC 4.3%

Value $3.644M Shares 173,049 Share Price $21.06 Est. Cost/Share $21.06 Unrealized @ Report Date —

VCEL VERICEL CORP 4.2%

Value $3.552M Shares 1,376,887 Share Price $2.58 * Est. Cost/Share $2.24 Unrealized @ Report Date 0.0%

ENTA ENANTA PHARMACEUTICALS INC 2.8%

Value $2.349M Shares 71,147 Share Price $33.02 Est. Cost/Share $32.59 Unrealized @ Report Date 0.0%

— DERMA SCIENCES INC 2.7%

Value $2.321M Shares 507,799 Share Price $4.57 Est. Cost/Share $4.57 Unrealized @ Report Date —

— CUTERA INC 1.5%

Value $1.279M Shares 100,000 Share Price $12.79 Est. Cost/Share $12.79 Unrealized @ Report Date —

— RECRO PHARMA INC 1.2%

Value $1.052M Shares 116,901 Share Price $9.00 Est. Cost/Share $9.00 Unrealized @ Report Date —

Ticker	Issuer	Shares	Value	%	Share Price	Est. Cost/Share	Unrealized @ Report Date	Class	CUSIP
VNDA	VANDA PHARMACEUTICALS INC	1,918,929	$17.86M	20.9%	$9.31 *	$9.98	0.0%	COM	921659108
—	CTI BIOPHARMA CORP	10,698,618	$13.16M	15.4%	$1.23	$1.23	—	COM	12648L106
—	SCICLONE PHARMACEUTICALS INC	1,175,574	$10.81M	12.7%	$9.20	$9.20	—	COM	80862K104
—	TOBIRA THERAPEUTICS INC	833,377	$8.375M	9.8%	$10.05	$10.05	—	COM	88883P101
—	SAGENT PHARMACEUTICALS INC	462,824	$7.364M	8.6%	$15.91	$15.91	—	COM	786692103
—	PERNIX THERAPEUTICS HOLDINGS	2,484,649	$7.33M	8.6%	$2.95	$2.95	—	COM	71426V108
—	PAIN THERAPEUTICS INC	3,575,000	$6.256M	7.3%	$1.75	$1.75	—	COM	69562K100
—	FOUNDATION MEDICINE INC	173,049	$3.644M	4.3%	$21.06	$21.06	—	COM	350465100
VCEL	VERICEL CORP	1,376,887	$3.552M	4.2%	$2.58 *	$2.24	0.0%	COM	92346J108
ENTA	ENANTA PHARMACEUTICALS INC	71,147	$2.349M	2.8%	$33.02	$32.59	0.0%	COM	29251M106
—	DERMA SCIENCES INC	507,799	$2.321M	2.7%	$4.57	$4.57	—	COM	249827502
—	CUTERA INC	100,000	$1.279M	1.5%	$12.79	$12.79	—	COM	232109108
—	RECRO PHARMA INC	116,901	$1.052M	1.2%	$9.00	$9.00	—	COM	75629F109